Sanara MedTech Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	107.51	103.12	86.67	64.99	45.84	24.14
Revenue Growth (YoY)	17.41%	18.97%	33.36%	41.77%	89.87%	54.90%
Cost of Revenue	7.61	7.52	8.14	7.85	6.36	2.31
Gross Profit	99.9	95.6	78.53	57.14	39.48	21.83
Selling, General & Admin	83.39	78.72	71.67	56.99	45.98	28.05
Depreciation & Amortization Expenses	2.98	2.66	2.79	3.68	2.37	0.6
Research & Development	5.08	5.07	2.83	4.13	3.37	0.56
Other Operating Expenses	1.84	1.84	-0.01	-3.45	0.28	-
Total Operating Expenses	93.29	88.29	77.27	61.35	52	29.21
Operating Income	7.66	7.3	1.26	-4.22	-12.52	-7.38
Interest Income	0.01	0	0.02	-	-	-
Interest Expense	-7.24	-6.76	-3.13	-0.48	-0.38	-0
Other Non-Operating Income (Expense)	-1.27	-0.94	-0.09	0.25	-1.04	-0.62
Total Non-Operating Income (Expense)	-8.5	-7.7	-3.2	-0.22	-1.42	-0.62
Pretax Income	-0.84	-0.39	-1.94	-4.44	-13.94	-7.99
Provision for Income Taxes	-	-	-	-	-5.84	-
Net Income	-33.58	-37.56	-9.66	-4.3	-7.94	-7.92
Minority Interest in Earnings	-0.01	-0.01	-0.49	-0.14	-0.15	-0.07
Earnings From Discontinued Operations	-31.69	-37.17	-7.97	-	-	-
Net Income to Common	-33.58	-37.56	-9.66	-4.3	-7.94	-7.92
Shares Outstanding (Basic)	9	9	8	8	8	7
Shares Outstanding (Diluted)	9	9	8	8	8	7
Shares Change (YoY)	2.01%	1.64%	2.48%	4.71%	7.70%	28.02%
EPS (Basic)	-0.27	-4.36	-1.14	-0.52	-1.00	-1.08
EPS (Diluted)	-0.28	-4.36	-1.14	-0.52	-1.00	-1.08
Shares Outstanding	9.17	8.95	8.75	8.54	8.3	7.68
Free Cash Flow	3.37	2.16	-0.23	-3.51	-5.7	-4.99
Free Cash Flow Growth	56.10%	-	-	-	-	-
Free Cash Flow Per Share	0.39	0.25	-0.03	-0.42	-0.72	-0.68
Gross Margin	92.92%	92.71%	90.61%	87.92%	86.12%	90.43%
Operating Margin	7.12%	7.08%	1.45%	-6.49%	-27.30%	-30.55%
Profit Margin	0.12%	-0.38%	-2.24%	-6.83%	-17.65%	-33.11%
FCF Margin	3.14%	2.10%	-0.26%	-5.40%	-12.44%	-20.65%
EBITDA	11.07	11.25	6.18	-0.54	-10.15	-6.78
EBITDA Margin	10.29%	10.91%	7.13%	-0.83%	-22.13%	-28.08%
EBIT	7.66	7.3	1.26	-4.22	-12.52	-7.38
EBIT Margin	7.12%	7.08%	1.45%	-6.49%	-27.30%	-30.55%
Effective Tax Rate	-	0.00%	0.00%	0.00%	41.94%	0.00%

SEC Filings: 10-K · 10-Q